Investor type
VC
Founded
2022
AUM
$500 M
Location
New York, New York, United States
$10-50 m
Investment Ticket
3-5 years
Investment Horizon
Pre-seed,
Seed
Investment Stage
Sale to strategic investor,
IPO,
Add-on acquisitions
Exit Strategy
Investor profile last updated: 27 July, 2026
Profile
Ascertain an agentic AI platform that delivers end-to-end automation across care management and revenue cycle workflows. Unlike static RPA or point solutions, Ascertain ingests structured and unstructured data, adapts in real time to new rules, and operates with explainable, auditable guardrails. Health systems, providers and payers achieve measurable ROI in months, not years — from faster authorizations to reduced cancellations and improved throughput.
Industry
Region of investment
Ascertain Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Fund I
|
Venture Capital (VC)
|
Healthcare Services
AI
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$100 M
|
April 2022
|
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!
FAQs about Ascertain
Where is Ascertain located?
Ascertain is located in New York, New York, United States.
When was Ascertain founded?
Ascertain was founded in 2022.
What sectors and industries does Ascertain invest in?
Ascertain invests in companies and startups in Healthcare Services, AI, HealthTech.
What is Ascertain geographical focus of investments?
Ascertain invests in companies and startups in North America.
At what stages of companies and startups does Ascertain typically invest in?
Ascertain invests in companies and startups at Pre-seed, Seed.
What is the usual amount of Ascertain investment?
Ascertain usually invests $10-50 m on average.
What is the amount of assets of under management (AUM) for Ascertain?
Ascertain has around $500m assets under management.
When was Ascertain last fund created?
Ascertain last fund was created/launched in 2022-04-14